Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).
- DOI
- 10.1136/bmjopen-2021-053190
- Published
- 2021 Nov 8
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2021-053190,
title = {Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).},
author = {Brennan PN and MacMillan M and Manship T and Moroni F and Glover A and Graham C and Semple S and Morris DM and Fraser AR and Pass C and McGowan NWA and Turner ML and Lachlan N and Dillon JF and Campbell JDM and Fallowfield JA and Forbes SJ},
year = {2021},
journal = {BMJ open},
doi = {10.1136/bmjopen-2021-053190},
url = {https://doi.org/10.1136/bmjopen-2021-053190}
}RIS
TY - JOUR TI - Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). AU - Brennan PN AU - MacMillan M AU - Manship T AU - Moroni F AU - Glover A AU - Graham C AU - Semple S AU - Morris DM AU - Fraser AR AU - Pass C AU - McGowan NWA AU - Turner ML AU - Lachlan N AU - Dillon JF AU - Campbell JDM AU - Fallowfield JA AU - Forbes SJ PY - 2021 JO - BMJ open DO - 10.1136/bmjopen-2021-053190 UR - https://doi.org/10.1136/bmjopen-2021-053190 ER -
APA
PN, B., M, M., T, M., F, M., A, G., C, G., S, S., DM, M., AR, F., C, P., NWA, M., ML, T., N, L., JF, D., JDM, C., JA, F., & SJ, F. (2021). Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).. BMJ open. https://doi.org/10.1136/bmjopen-2021-053190
Source records
- pubmed · retrieved 2026-09-26T18:50:08.922Z